Manufactured by:ProteoGenix
Save 20%RUO

Recombinant Human RBM39 Protein, N-His

Recombinant Human RBM39 Protein, N-His from ProteoGenix; catalogue ARO-P12151; research use only.

SKU:
ABM142588-1
Manufacturer SKU
ARO-P12151
Product type
Recombinant Proteins
Expression systemProkaryotic expression

Manufacturer provenance

Manufactured by:
ProteoGenix
Sold by:
ABMIUM
Fulfilled from:
Manufacturer facility or confirmed fulfilment location

Know who made it. See the evidence. Buy through one marketplace.

Product description

Introduction

Recombinant Human RBM39 Protein, also known as RNA binding motif protein 39, is a protein that is encoded by the RBM39 gene in humans. This protein is a member of the RNA recognition motif (RRM) family and is involved in various cellular processes such as RNA splicing, transcription, and translation. In this article, we will discuss the structure, activity, and applications of Recombinant Human RBM39 Protein.

Structure of Recombinant Human RBM39 Protein

Recombinant Human RBM39 Protein is composed of 356 amino acids and has a molecular weight of approximately 40 kDa. It contains a single RNA recognition motif (RRM) domain, which is responsible for binding to RNA molecules. The RRM domain is a conserved structural motif that is found in many RNA-binding proteins and is involved in various RNA-related processes.

In addition to the RRM domain, Recombinant Human RBM39 Protein also contains a nuclear localization signal (NLS) and a nuclear export signal (NES). These signals allow the protein to shuttle between the nucleus and the cytoplasm, where it plays a role in regulating gene expression.

Activity of Recombinant Human RBM39 Protein

Recombinant Human RBM39 Protein is primarily involved in RNA splicing, which is the process of removing introns from pre-mRNA molecules to produce mature mRNA. It does this by binding to specific RNA sequences and recruiting other splicing factors to form a spliceosome complex. This complex then catalyzes the splicing reaction, resulting in the removal of introns and the joining of exons to produce mature mRNA.

In addition to its role in RNA splicing, Recombinant Human RBM39 Protein also plays a role in transcription and translation. It has been shown to interact with other proteins involved in these processes, such as RNA polymerase II and ribosomal proteins. This suggests that Recombinant Human RBM39 Protein may also be involved in regulating gene expression at the transcriptional and translational levels.

Applications of Recombinant Human RBM39 Protein

Due to its involvement in RNA-related processes, Recombinant Human RBM39 Protein has several potential applications in the field of molecular biology. One of its main applications is in the study of RNA splicing. By using recombinant RBM39 protein, researchers can investigate the role of this protein in splicing and its interactions with other splicing factors.

Recombinant Human RBM39 Protein can also be used in the development of new therapies for diseases that are caused by defects in RNA splicing. For example, mutations in the RBM39 gene have been linked to certain types of leukemia. By understanding the role of RBM39 protein in splicing, researchers may be able to develop targeted therapies to treat these diseases.

Furthermore, Recombinant Human RBM39 Protein has potential applications in the biotechnology industry. It can be used in the production of recombinant proteins, as it has been shown to interact with ribosomal proteins and enhance translation efficiency. This could be particularly useful in the production of difficult-to-express proteins.

Conclusion

In summary, Recombinant Human RBM39 Protein is a versatile protein that plays a crucial role in RNA-related processes. Its structure, activity, and potential applications make it a valuable tool for researchers in the fields of molecular biology and biotechnology. Further studies on this protein may lead to a better understanding of its functions and potential therapeutic applications.

ProteoGenix catalogue number ARO-P12151. For research use only.

Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 22.35 kDa; Fragment: Thr146-Val326; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..

Available configurations: 50ug, 100ug, 1mg.

Download the manufacturer datasheet

Key facts & specifications
Also known as
CAPER alpha, RNA-binding protein 39, RNA-binding region-containing protein 2, CAPERalpha, HCC1, RNPC2, RBM39, RNA-binding motif protein 39, Hepatocellular carcinoma protein 1, Splicing factor HCC1
Host species
E. coli
Source organism
Human
Molecular weight
22.35 kDa
Sequence fragment
Thr146-Val326
Sequence
TPEERDARTVFCMQLAARIRPRDLEEFFSTVGKVRDVRMISDRNSRRSKGIAYVEFVDVSSVPLAIGLTGQRVLGVPIIVQASQAEKNRAAAMANNLQKGSAGPMRLYVGSLHFNITEDMLRGIFEPFGRIESIQLMMDSETGRSKGYGFITFSDSECAKKALEQLNGFELAGRPMKVGHV
Technical note
For research use only.
Identifiers & database references
Manufacturer SKU
ARO-P12151
UniProt accession
Q14498
Storage, stability & shipping
Storage conditions
4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection)
Shipped at
Dry Ice
Compliance & documents
ISO certifications
ISO 9001:2023, ISO 14001: 2023
Datasheet
Open datasheet
Frequently asked questions
Who manufactured this product?

This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.

Can ABMIUM ship this product internationally?

ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.

Can I check suitability before ordering?

Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.

Is this product for clinical use?

Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.

ProteoGenix
£189.00£151.20